This content is restricted to members.
To view our premium content, sign up for a membership:
This content is restricted to members.
To view our premium content, sign up for a membership:
1. Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Frontiers in Aging Neuroscience. 2015;21;7.
2. Bradbury J. Docosahexaenoic acid (DHA): An ancient nutrient for the modern human brain. Nutrients. 2011;3(5):529–54.
3. Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L. Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. European Journal of Clinical Investigation. 2005;35(11):691–9.
4. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutrition & Metabolism. 2011;8(1):34.
5. Bell JG, Sargent JR, Tocher DR, Dick JR. Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders? Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA). 2000;63(1–2):21–5.
6. Vancassel S, Durand G, Barthélémy C, Lejeune B, Martineau J, Guilloteau D, et al. Plasma fatty acid levels in autistic children. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA). 2001;65(1):1–7.
7. Politi P, Cena H, Comelli M, Marrone G, Allegri C, Emanuele E, et al. Behavioral Effects of Omega-3 Fatty Acid Supplementation in Young Adults with Severe Autism: An Open Label Study. Archives of Medical Research. 2008;39(7):682–5.
8. Bent S, Bertoglio K, Hendren RL. Omega-3 Fatty Acids for Autistic Spectrum Disorder: A Systematic Review. Journal of Autism and Developmental Disorders. 2009;39(8):1145–54.
9. Chang JPC, Su KP, Mondelli V, Pariante CM. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies. Neuropsychopharmacology. 2018;43(3):534–45.
10. Bell JG, MacKinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen ACA. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2004;71(4):201–4.
11. Rex D. An Evidence-based, “Common Sense” Approach to the Evaluation of Dietary Interventions in ASD and ADHD. Food and Behaviour Research. 2010;1–6.